_version_ 1784852947111247872
author Payne, Amanda B.
Ray, Logan C.
Cole, Matthew M.
Canning, Michelle
Houck, Kennedy
Shah, Hazel J.
Farrar, Jennifer L.
Lewis, Nathaniel M.
Fothergill, Amy
White, Elizabeth B.
Feldstein, Leora R.
Roper, Lauren E.
Lee, Florence
Kriss, Jennifer L.
Sims, Emily
Spicknall, Ian H.
Nakazawa, Yoshinori
Gundlapalli, Adi V.
Shimabukuro, Tom
Cohen, Adam L.
Honein, Margaret A.
Mermin, Jonathan
Payne, Daniel C.
author_facet Payne, Amanda B.
Ray, Logan C.
Cole, Matthew M.
Canning, Michelle
Houck, Kennedy
Shah, Hazel J.
Farrar, Jennifer L.
Lewis, Nathaniel M.
Fothergill, Amy
White, Elizabeth B.
Feldstein, Leora R.
Roper, Lauren E.
Lee, Florence
Kriss, Jennifer L.
Sims, Emily
Spicknall, Ian H.
Nakazawa, Yoshinori
Gundlapalli, Adi V.
Shimabukuro, Tom
Cohen, Adam L.
Honein, Margaret A.
Mermin, Jonathan
Payne, Daniel C.
author_sort Payne, Amanda B.
collection PubMed
description
format Online
Article
Text
id pubmed-9762900
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-97629002022-12-23 Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 Payne, Amanda B. Ray, Logan C. Cole, Matthew M. Canning, Michelle Houck, Kennedy Shah, Hazel J. Farrar, Jennifer L. Lewis, Nathaniel M. Fothergill, Amy White, Elizabeth B. Feldstein, Leora R. Roper, Lauren E. Lee, Florence Kriss, Jennifer L. Sims, Emily Spicknall, Ian H. Nakazawa, Yoshinori Gundlapalli, Adi V. Shimabukuro, Tom Cohen, Adam L. Honein, Margaret A. Mermin, Jonathan Payne, Daniel C. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-12-09 /pmc/articles/PMC9762900/ /pubmed/36480479 http://dx.doi.org/10.15585/mmwr.mm7149a5 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Payne, Amanda B.
Ray, Logan C.
Cole, Matthew M.
Canning, Michelle
Houck, Kennedy
Shah, Hazel J.
Farrar, Jennifer L.
Lewis, Nathaniel M.
Fothergill, Amy
White, Elizabeth B.
Feldstein, Leora R.
Roper, Lauren E.
Lee, Florence
Kriss, Jennifer L.
Sims, Emily
Spicknall, Ian H.
Nakazawa, Yoshinori
Gundlapalli, Adi V.
Shimabukuro, Tom
Cohen, Adam L.
Honein, Margaret A.
Mermin, Jonathan
Payne, Daniel C.
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
title Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
title_full Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
title_fullStr Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
title_full_unstemmed Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
title_short Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
title_sort reduced risk for mpox after receipt of 1 or 2 doses of jynneos vaccine compared with risk among unvaccinated persons — 43 u.s. jurisdictions, july 31–october 1, 2022
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762900/
https://www.ncbi.nlm.nih.gov/pubmed/36480479
http://dx.doi.org/10.15585/mmwr.mm7149a5
work_keys_str_mv AT payneamandab reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT rayloganc reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT colematthewm reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT canningmichelle reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT houckkennedy reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT shahhazelj reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT farrarjenniferl reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT lewisnathanielm reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT fothergillamy reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT whiteelizabethb reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT feldsteinleorar reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT roperlaurene reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT leeflorence reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT krissjenniferl reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT simsemily reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT spicknallianh reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT nakazawayoshinori reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT gundlapalliadiv reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT shimabukurotom reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT cohenadaml reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT honeinmargareta reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT merminjonathan reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022
AT paynedanielc reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022